Denver, CO, United States of America

S Kent Peterson

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Hauser Chemical Research, Inc., Hauser, Inc.. Active years: 1994-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: S Kent Peterson. Retrieved from https://idiyas.com/inventor/s-kent-peterson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1994-1998

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: S Kent Peterson: Innovator in Taxol and Docetaxel Preparation

Introduction

S Kent Peterson is a notable inventor based in Denver, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of Taxol and docetaxel. With a total of 4 patents to his name, Peterson's work has advanced the efficiency of producing these vital compounds.

Latest Patents

One of Peterson's latest patents focuses on the "Preparation of Taxol and docetaxel through primary amines." This invention describes a process for converting Taxol A, B, and C into Taxol primary amine, which can then be efficiently transformed into Taxol A or docetaxel. This method significantly increases the yield of these products from biomass. The process involves the removal of the amide from the side-chain using Schwartz's reagent to form an imine, followed by hydrolysis of the imine to produce the primary amine. The primary amine can subsequently be converted into Taxol A or docetaxel. Additionally, new Taxol imine compounds and primary amine salts have been developed through this innovative process.

Career Highlights

Throughout his career, S Kent Peterson has worked with various companies, including Hauser, Inc. and Hauser Chemical Research, Inc. His expertise in the pharmaceutical industry has allowed him to contribute to advancements in drug preparation and yield optimization.

Collaborations

Some of Peterson's notable coworkers include Christopher K Murray and Xiaoqin Cheng. Their collaborative efforts have further enhanced the research and development of pharmaceutical processes.

Conclusion

S Kent Peterson's innovative work in the preparation of Taxol and docetaxel has made a significant impact on the pharmaceutical industry. His patents reflect a commitment to improving the efficiency of drug production, which is crucial for advancing medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…